Long-term stability of the Glide prosthesis control system

Determining the Long-Term Stability of the Glide Control Strategy for Upper Limb Prostheses

NA · Infinite Biomedical Technologies · NCT07222085

This comparison tests whether the Glide control system makes using and managing an advanced myoelectric arm easier for adults with an upper-limb amputation than pattern-recognition control.

Quick facts

PhaseNA
Study typeInterventional
Enrollment12 (estimated)
Ages18 Years and up
SexAll
SponsorInfinite Biomedical Technologies (industry)
Locations10 sites (Annapolis, Maryland and 9 other locations)
Trial IDNCT07222085 on ClinicalTrials.gov

What this trial studies

Adults with a healed unilateral trans-radial or trans-humeral amputation who are candidates for a 2+ degree-of-freedom myoelectric prosthesis will be fitted with either the Glide control system or a pattern-recognition control system and followed over time. The study will measure burden of use for both patients and their clinical care teams, device stability, usability, and implications for prosthesis prescription and rehabilitation. People with prior Glide or pattern-recognition experience, unhealed residual limbs, skin sensitivity, or significant cognitive, neurological, or medical problems are excluded. Results are intended to fill gaps in clinically relevant knowledge to guide which control systems clinicians prescribe and how rehabilitation is delivered.

Who should consider this trial

Good fit: Adults 18 or older with a healed unilateral trans-radial or trans-humeral amputation who are candidates for a 2+ DOF myoelectric prosthesis and have no prior Glide or pattern-recognition experience.

Not a fit: People with unhealed residual limbs, easily damaged or sensitive skin, significant cognitive/neurological/physical deficits, uncontrolled pain, serious uncontrolled medical problems, or prior Glide/PR experience are unlikely to be eligible or to benefit.

Why it matters

Potential benefit: If successful, this could make advanced myoelectric prostheses easier to use and reduce clinical workload, improving long-term use and patient satisfaction.

How similar studies have performed: Pattern-recognition myoelectric control has shown promise in laboratory and short-term clinical work, but long-term real-world benefits have been mixed and long-term data on Glide control are limited.

Eligibility criteria

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Unilateral trans-radial or trans-humeral limb loss with a healed residual limb
* Candidate for 2+ degree-of-freedom (DOF) myoelectric prosthesis as determined by the study prosthetist
* Age of 18 years or greater

Exclusion Criteria:

* Prior experience with Pattern Recognition or Glide control
* Individuals with a residual limb that is unhealed from the amputation surgery
* Individuals with easily damaged or sensitive skin who would not tolerate EMG electrodes
* Significant cognitive deficits as determined upon clinical evaluation
* Significant neurological deficits as determined upon clinical evaluation
* Significant physical deficits of the residual limb impacting full participation in the study as determined upon clinical evaluation
* Uncontrolled pain or phantom pain impacting full participation in the study as determined upon clinical evaluation
* Serious uncontrolled medical problems

Where this trial is running

Annapolis, Maryland and 9 other locations

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.

View on ClinicalTrials.gov →

Conditions: Upper Limb Amputation Above Elbow, Upper Limb Amputation Below Elbow, Glide, Pattern Recognition, Myoelectric Control, Upper Limb Prostheses

Last reviewed 2026-05-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.